Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era
-
Published:2022-12-01
Issue:2
Volume:9
Page:1-17
-
ISSN:1727-3706
-
Container-title:Vaccine Research
-
language:en
-
Short-container-title:vacres
Author:
Possas Cristina,
Antunes Adelaide,
Oliveira Alessandra,
Schumacher Suzanne,
Marques Ernesto TA,
Homma AkiraORCID
Publisher
Apex Publishing
Reference107 articles.
1. Pierson TC, Diamond MS. The Continued Emerging Threat of Flaviviruses. Nature Microbiology. 2020;5(6):796-812.
2. Pandit PS, Doyle MM, Smart KM, Young CCW, Drape GW, Johnson CK. Predicting wildlife reservoirs and global vulnerability to zoonotic Flaviviruses. Nat Commun. 2018;9(5425):1-10.
3. Organization PAH: Cases of dengue in the Americas exceeded 3 million in 2019.
4. Piot P, Larson HJ, O’Brien KL, N’kengasong J, Ng E, Sow S, et al. Immunization: vital progress, unfinished agenda. Nature. 2019;575(7781):119-29.
5. Gerberding JL, Haynes BF. Vaccine Innovations — Past and Future. The New England Journal of medicine. 2021;384:393-6.